Clinics Drive Exponential Growth in the UK’s Medical Cannabis Market

The UK medical cannabis market has experienced remarkable growth, with over 120,000 privately prescribed items in 2022 alone. This article delves into the factors driving this growth, including the thriving private clinic sector, improved affordability, and diverse product offerings. It also provides a comparative analysis with European models and discusses future trends and opportunities. With […]
Cannabis for war veterans? PTSD in medical cannabis access schemes

Ukraine made the headlines in July 2023 with the announcement of medical cannabis legalisation, in a move with the stated goal to cope with the psychological long-lasting effects of war, and trauma of combat veterans in particular. Today at Cannamonitor we are discussing the body of evidence regarding the use of cannabis for PTSD, as well […]
The Good, the Bad and the Ugly of the German model of legalisation

An update by the German Health and Agriculture Ministers on the key points of cannabis legalisation has left a bittersweet aftertaste for many cannabis industry stakeholders. Plans of a nation-wide, fully regulated market announced in October have been watered down to a strong decriminalisation model with home-growing and clubs, to be unfolded immediately, and regional scientific […]